STENO — StenoCare A/S Income Statement
0.000.00%
Last trade - 00:00- DKK40.86m
- DKK42.06m
- DKK7.02m
Annual income statement for StenoCare A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.89 | 4.49 | 3.76 | 2.23 | 7.02 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 16 | 21 | 19.7 | 35.3 | 8.79 |
| Operating Profit | -14.1 | -16.5 | -15.9 | -33.1 | -1.77 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -14.3 | -17.9 | -18.8 | -34.6 | -2.39 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12.7 | -16.3 | -17.6 | -34.5 | -2.39 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -12.7 | -16.3 | -17.6 | -34.5 | -2.39 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.7 | -16.3 | -17.6 | -34.5 | -2.39 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.596 | -0.738 | -0.534 | -0.657 | -0.056 |
| Dividends per Share |